VISEN PHARMACEUTICALS's next confirmed earnings release is scheduled for April 1, 2027.
| Earnings Date | 4/1/2027 |
As of June 30, 2026, VISEN PHARMACEUTICALS has 109.30M shares outstanding.
| Shares Outstanding | 109.30M |
As of June 30, 2026, VISEN PHARMACEUTICALS maintains a current ratio of 4.00, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.00 |
| Quick Ratio | 2.38 |
| Debt / Equity | 26.33 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 82.00 |
As of June 30, 2026, VISEN PHARMACEUTICALS holds 74.55M in cash and equivalents against 26.05M in total debt, resulting in a net debt position of -49.48M. Total book value stands at 98.94M, with working capital of 93.93M providing operational flexibility.
| Cash & Cash Equivalents | 74.55M |
| Total Debt | 26.05M |
| Net Debt | -49.48M |
| Equity (Book Value) | 98.94M |
| Book Value Per Share | 0.91 |
| Working Capital | 93.93M |
Already premium?